Highly efficient hyaluronic acid conjugation technology and its applications in biopharmaceutical industry
Our team has developed a hyaluronic acid-drug conjugation technology to create a polymer nanoparticle drug delivery system. It significantly enhances the grafting efficiency of hydrophobic drugs onto hyaluronic acid, reduces byproduct formation, and improves solubility. These hyaluronic acid conjugates, with targeted delivery and immune modulation properties, have been licensed and advanced to USFDA Phase II clinical trials, along with several preclinical drug and immune adjuvant developments.
A deep learning-powered novel artificial intelligence algorithm and syste m to assist in the identification of pneumoperitoneum on abdominal com puted tomography
Vesicles comprising lectins expressed on the surface and methods of use thereof to deliver an agent to autophagic and apoptotic cells
Artificial Intelligence Acute Kidney Injury Prediction: Real-time Inference and Interactive Critical Care System
Bioinspired Artificial Ligament Fabricated by Interfacial Polyelectrolyte Complexation Technique for Ligament Regeneration
Technology maturity：Trial production
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!